These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 30394326)

  • 1. Dorsal striatum does not mediate feedback-based, stimulus-response learning: An event-related fMRI study in patients with Parkinson's disease tested on and off dopaminergic therapy.
    Hiebert NM; Owen AM; Ganjavi H; Mendonça D; Jenkins ME; Seergobin KN; MacDonald PA
    Neuroimage; 2019 Jan; 185():455-470. PubMed ID: 30394326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dopamine modulates striatal response to reward and punishment in patients with Parkinson's disease: a pharmacological challenge fMRI study.
    Argyelan M; Herzallah M; Sako W; DeLucia I; Sarpal D; Vo A; Fitzpatrick T; Moustafa AA; Eidelberg D; Gluck M
    Neuroreport; 2018 May; 29(7):532-540. PubMed ID: 29432300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Striatum in stimulus-response learning via feedback and in decision making.
    Hiebert NM; Vo A; Hampshire A; Owen AM; Seergobin KN; MacDonald PA
    Neuroimage; 2014 Nov; 101():448-57. PubMed ID: 25038436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parkinson's disease duration determines effect of dopaminergic therapy on ventral striatum function.
    MacDonald AA; Monchi O; Seergobin KN; Ganjavi H; Tamjeedi R; MacDonald PA
    Mov Disord; 2013 Feb; 28(2):153-60. PubMed ID: 23165957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dorsal striatum mediates deliberate decision making, not late-stage, stimulus-response learning.
    Hiebert NM; Owen AM; Seergobin KN; MacDonald PA
    Hum Brain Mapp; 2017 Dec; 38(12):6133-6156. PubMed ID: 28945307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of dopamine therapy on ventral and dorsal striatum-mediated cognition in Parkinson's disease: support from functional MRI.
    MacDonald PA; MacDonald AA; Seergobin KN; Tamjeedi R; Ganjavi H; Provost JS; Monchi O
    Brain; 2011 May; 134(Pt 5):1447-63. PubMed ID: 21596772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopaminergic basis for impairments in functional connectivity across subdivisions of the striatum in Parkinson's disease.
    Bell PT; Gilat M; O'Callaghan C; Copland DA; Frank MJ; Lewis SJ; Shine JM
    Hum Brain Mapp; 2015 Apr; 36(4):1278-91. PubMed ID: 25425542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Greater striatal responses to medication in Parkinson׳s disease are associated with better task-switching but worse reward performance.
    Aarts E; Nusselein AA; Smittenaar P; Helmich RC; Bloem BR; Cools R
    Neuropsychologia; 2014 Sep; 62():390-7. PubMed ID: 24912070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional specialization within the striatum along both the dorsal/ventral and anterior/posterior axes during associative learning via reward and punishment.
    Mattfeld AT; Gluck MA; Stark CE
    Learn Mem; 2011; 18(11):703-11. PubMed ID: 22021252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oscillatory subthalamic nucleus activity is modulated by dopamine during emotional processing in Parkinson's disease.
    Huebl J; Spitzer B; Brücke C; Schönecker T; Kupsch A; Alesch F; Schneider GH; Kühn AA
    Cortex; 2014 Nov; 60():69-81. PubMed ID: 24713195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of levodopa on stimulus-response learning versus response selection in healthy young adults.
    Vo A; Seergobin KN; MacDonald PA
    Behav Brain Res; 2017 Jan; 317():553-561. PubMed ID: 27743941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ventral striatal network connectivity reflects reward learning and behavior in patients with Parkinson's disease.
    Petersen K; Van Wouwe N; Stark A; Lin YC; Kang H; Trujillo-Diaz P; Kessler R; Zald D; Donahue MJ; Claassen DO
    Hum Brain Mapp; 2018 Jan; 39(1):509-521. PubMed ID: 29086460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Levodopa influences striatal activity but does not affect cortical hyper-activity in Parkinson's disease.
    Martinu K; Degroot C; Madjar C; Strafella AP; Monchi O
    Eur J Neurosci; 2012 Feb; 35(4):572-83. PubMed ID: 22304628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Different effects of dopaminergic medication on perceptual decision-making in Parkinson's disease as a function of task difficulty and speed-accuracy instructions.
    Huang YT; Georgiev D; Foltynie T; Limousin P; Speekenbrink M; Jahanshahi M
    Neuropsychologia; 2015 Aug; 75():577-87. PubMed ID: 26184442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. l-DOPA changes ventral striatum recruitment during motor sequence learning in Parkinson's disease.
    Kwak Y; Müller ML; Bohnen NI; Dayalu P; Seidler RD
    Behav Brain Res; 2012 Apr; 230(1):116-24. PubMed ID: 22343069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Levodopa improves response inhibition and enhances striatal activation in early-stage Parkinson's disease.
    Manza P; Schwartz G; Masson M; Kann S; Volkow ND; Li CR; Leung HC
    Neurobiol Aging; 2018 Jun; 66():12-22. PubMed ID: 29501966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dopaminergic medication reduces striatal sensitivity to negative outcomes in Parkinson's disease.
    McCoy B; Jahfari S; Engels G; Knapen T; Theeuwes J
    Brain; 2019 Nov; 142(11):3605-3620. PubMed ID: 31603493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decisions under risk in Parkinson's disease: preserved evaluation of probability and magnitude.
    Sharp ME; Viswanathan J; McKeown MJ; Appel-Cresswell S; Stoessl AJ; Barton JJ
    Neuropsychologia; 2013 Nov; 51(13):2679-89. PubMed ID: 23954375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dose dependent dopaminergic modulation of reward-based learning in Parkinson's disease.
    van Wouwe NC; Ridderinkhof KR; Band GP; van den Wildenberg WP; Wylie SA
    Neuropsychologia; 2012 Apr; 50(5):583-91. PubMed ID: 22223079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ageing and early-stage Parkinson's disease affect separable neural mechanisms of mesolimbic reward processing.
    Schott BH; Niehaus L; Wittmann BC; Schütze H; Seidenbecher CI; Heinze HJ; Düzel E
    Brain; 2007 Sep; 130(Pt 9):2412-24. PubMed ID: 17626038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.